The head-to-head comparison between escitalopram and mirtazapine for anxiety and agitation on the patients with depression, especially for the efficacy and safety.

The head-to-head comparison between escitalopram and mirtazapine for anxiety and agitation on the patients with depression, especially for the efficacy and safety. - The head-to-head comparison between escitalopram and mirtazapine on the patients with depression.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014609

Enrollment

Registered

2014-07-23

Start date

2014-07-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

escitalopram mirtazapine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The adult patients with depression

Exclusion criteria

Exclusion criteria: The patients who does not have the insight

Design outcomes

Primary

Measure	Time frame
Clinical symptom scaled by HAM-A, HAM-D, and MADRS	—

Countries

Japan

Contacts

Public ContactTetsufumi Kanazawa

Osaka Medical College Neuropsychiatry dept

psy052@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026